Cost-Saving Early Diagnosis of Functional Pain in Nonmalignant Pain: A Noninferiority Study of Diagnostic Accuracy. by Cámara, Rafael J A et al.
Research Article
Cost-Saving Early Diagnosis of Functional Pain in Nonmalignant
Pain: A Noninferiority Study of Diagnostic Accuracy
Rafael J. A. Cámara,1 Christian Merz,2 Barbara Wegmann,2 Stefanie Stauber,3
Roland von Känel,4,5 and Niklaus Egloff2
1University Medical Center of the Johannes Gutenberg University, Mainz, Institute of Medical Biostatistics,
Epidemiology, and Informatics, Obere Zahlbacher Straße 69, 55131 Mainz, Germany
2Department of General Internal Medicine, Division of Psychosomatic Medicine, Inselspital,
Bern University Hospital, 3010 Bern, Switzerland
3Heart Failure and Transplantation, Department of Cardiology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland
4Department of Psychosomatic Medicine, Clinic Barmelweid, 5017 Barmelweid, Switzerland
5Department of Neurology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland
Correspondence should be addressed to Rafael J. A. Ca´mara; racamara@uni-mainz.de
Received 3 December 2015; Revised 20 January 2016; Accepted 1 February 2016
Academic Editor: Donald A. Simone
Copyright © 2016 Rafael J. A. Ca´mara et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objectives. We compared two index screening tests for early diagnosis of functional pain: pressure pain measurement by electronic
diagnostic equipment, which is accurate but too specialized for primary health care, versus peg testing, which is cost-saving
and more easily manageable but of unknown sensitivity and specificity. Early distinction of functional (altered pain perception;
nervous sensitization) from neuropathic or nociceptive pain improves painmanagement.Methods. Clinicians blinded for the index
screening tests assessed the reference standard of this noninferiority diagnostic accuracy study, namely, comprehensive medical
history taking with all previous findings and treatment outcomes. All consenting patients referred to a university hospital for
nonmalignantmusculoskeletal pain participated.Themain analysis compared the receiver operating characteristic (ROC) curves of
both index screening tests. Results. The area under the ROC curve for peg testing was not inferior to that of electronic equipment:
it was at least 95% as large for finger measures (two-sided 𝑝 = 0.038) and at least equally as large for ear measures (two-sided
𝑝 = 0.003). Conclusions. Routine diagnostic testing by peg, which is accessible for general practitioners, is at least as accurate as
specialized equipment. This may shorten time-to-treatment in general practices, thereby improving the prognosis and quality of
life.
1. Introduction
The lifetime prevalence of chronic nonmalignant muscu-
loskeletal pain varies between 13.5% and 47% in the general
population [1]. In one-third of these patients, this pain is
“functional,” which is defined as not explainable by lesions or
inflammations of tissues or nerves [2, 3]. Because, as opposed
to nociceptive and neuropathic pain, surgery and the anal-
gesics scheme recommended by the World Health Organiza-
tion are not adequate for functional pain, the distinction is
clinically relevant (International Statistical Classification of
Diseases and Related Health Problems: F45.40 and F45.41).
Functional pain requires specialized multicomponent man-
agement involving physical exercise, activating physiother-
apy, electrical, thermal, and tactile stimulation, relaxation
techniques, psychological support, tricyclic antidepressants,
andmuscle relaxants [4]. Functional painmayoccur as an iso-
lated entity or as the dominant symptomof “central sensitivity
syndromes” such as fibromyalgia [5, 6], whereby the func-
tional alteration of the nervous system is probably involved
[7, 8].
A delay of eight years on average to classify pain as either
functional, nociceptive, or neuropathic increases expendi-
tures and reduces the prognosis and the quality of life of
Hindawi Publishing Corporation
Pain Research and Treatment
Volume 2016, Article ID 5964250, 7 pages
http://dx.doi.org/10.1155/2016/5964250
2 Pain Research and Treatment
the patients [3, 4, 9, 10]. Because imaging and laboratory
findings often seem to correspond to the symptoms at the first
evaluation, diagnosing functional pain by the exclusion of
nociceptive andneuropathic pain is difficult [3, 8].Whenpain
is functional, namely, prolonged by central nervous system
sensitization [5, 7], nociceptive stimuli such as whiplash-
associated pain syndrome or osteoarthritis and inflammation
are oftenmistaken for its cause [3, 11–13].The diagnostic pro-
cess involves repetitions of, for instance, computer tomogra-
phies, electromyographies, infiltrations of local anesthetics,
surgery, and extensive laboratory examinations [3].
Despite the importance of distinguishing functional from
nociceptive and neuropathic pain early, screening tests are
still missing in primary care [4, 11–13]. Techniques tomeasure
pressure pain sensitivity, summarized as electronic algome-
try, are very precise (one kilopascal), but expensive, and thus
only used in specialized centers and studies [14–17]. They
show that the pain threshold is reduced in many functional
pain syndromes [5–7]. While electronic algometry is indis-
pensable for research, cost-effective andmore easily manage-
able alternatives are required for functional pain screening in
primary care [18].
Our hypothesis was that peg algometry’s ability to distin-
guish functional from nociceptive and neuropathic pain is
not inferior to that of electronic algometry, which has been
widely investigated but is many times more costly than peg
algometry and only used by specialists.The latter is a recently
introduced test performed with a pressure pain device that
easily fits into a coat pocket.Wehad shown that peg algometry
is very reliable and consistent according to criteria of the
British Standards Institution [19, 20]. For instance, standard-
ized Bland Altman repeatability coefficients were 0.96 for
finger peg algometry and even 0.63 for ear peg algometry.
Moreover, 95% of the differences between test and retest
results were within two standard deviations from “no differ-
ence” for ear lobe, and even within one standard deviation for
middle finger peg algometry, with all 𝑝 values <0.001.
2. Methods
The enrolment and data collection for this noninferiority
study of diagnostic accuracy comparing the two index tests,
namely, peg with electronic algometry, were carried out at
the Clinical Departments for Psychosomatic Medicine and
for Orthopedics at the Bern University Hospital. The local
ethics committee had approved the study protocol. All eligible
patients were informed about the study. The main eligibility
criteria were hospitalization for nonmalignantmusculoskele-
tal pain and written informed consent. Further eligibility
criteriawere the absence of local lesions at the site ofmeasure-
ment or at an efferent innervation of this site.
Following eligibility assessment, an advanced medical
student read the index tests, and the attending specialists,
who ignored the readings of the index tests, assessed the ref-
erence standard. All passed their written results to the
data manager. The enrolment continued until at least 60
patients with functional and 60 patients with nociceptive or
neuropathic pain consented (see “analysis and presentation of
data”). The STARD checklist for reporting studies on diag-
nostic accuracy [21] was followed for reporting the introduc-
tion, methods, and results part (see SupplementaryMaterial 1
available online at http://dx.doi.org/10.1155/2016/5964250),
and the STROBE checklist [22] was used for the discussion.
The reference standard for comparing the two index tests
was a thorough review of the medical history including clin-
ical, imaging, arthroscopic, and surgical findings and treat-
ment outcomes according to the criteria of the International
Statistical Classification of Diseases and RelatedHealth Prob-
lems. By reviewing pain histories of eight years on average,
exclusion of alternate pain causes and little effect of con-
ventional analgesics confirmed functional pain [23]. The
correlation of the localization and character of pain symp-
tomatology with clinical and investigative findings from the
patients’ histories corroborated nociceptive or neuropathic
pain. Functional pain was found, for instance, in somatoform
pain, fibromyalgia, complex regional pain syndrome, chronic
temporomandibular joint disorder, whiplash disorder, and
chronic low back pain, as well as combinations of such dis-
orders. However, neither the given diagnosis nor any central
nervous system hypersensitivity testing was our reference
standard, but rather a long and costly exclusion of lesions,
degenerations, and inflammations of tissues or nerves which
could have explained the pain, as well as failure of conven-
tional pain treatment [2, 3].
Combinations of functional and nociceptive pain were
classified as functional pain. Such combinations are frequent
[24], and early diagnosis of the functional pain component is
as important in such combinations as in isolated functional
pain. Missing neither the one nor the other remains a chal-
lenge.Having said that, the focus of this studywas the identifi-
cation of patients requiring multicomponent pain treatment,
fromwhichmost patients with functional painmight benefit,
whether or not they also have nociceptive pain.
Standardized pegs of polypropylene were used for peg
algometry [20], and a device that had been tested in multiple
studies and is regularly employed in pain research was used
for electronic algometry according to the manufacturer’s
instructions [25]. Whether to start with peg or with elec-
tronic algometry was determined by flipping a coin. Both
algometry techniqueswere applied to the distal phalanx of the
middle finger and then to the ear lobe. Measurements were
performed at the left and the right side of the body in order
to control for side-specific differences of perception [26].
A pause of one minute before each measurement aimed to
minimize sensitization phenomena. Finger algometry was
conducted without touching the nail fold, and ear algometry
was performed in themiddle of the ear lobe without touching
cartilaginous structures. All algometry results were immedi-
ately documented for later calculation of the mean between
the left and the right side.
The peg was left in place for 10 seconds. Before removing
it, the study participants rated their pain sensitivity numeri-
cally on a scale from 0 to 10 with intervals of 0.5, where “0”
was “no pain at all” and “10” was “the worst imaginable pain.”
Each of the four anatomical sites (left and right middle finger
as well as left and right ear lobe) was measured once.
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No informed consent: 9
Hospitalized for musculoskeletal pain: 166
Functional pain: 68 Nociceptive pain: 89
Conclusive result for both index tests: 157
Conclusive reference standard: 157
Figure 1: Flow of a referred sample of 166 individuals hospitalized for musculoskeletal pain. The reference standard, namely, a thorough
review of the clinical pain history including past investigations and pharmacological responses, revealed 68 participants with functional and
89 participants with nociceptive pain.
In contrast to peg algometry, electronic algometry increa-
sed the pressure at 50 kilopascals per second until the
study participants experienced the pressure as pain. At that
moment, they pressed a button to display the pressure pain
threshold in kilopascals. To proceed as recommended by the
manufacturer, electronic algometry was conducted three
times for each of the anatomical sites (see the previous para-
graph), and the average of the three readings was computed
before computing the average between the left and right sides.
In order to address potential interviewer-bias and com-
peting interests, the reader of the index tests knew that the
internal consistency of peg and electronic algometry would
be investigated but ignored the reference standard and the
diagnostic accuracy comparison [20]. She was involved nei-
ther in the assessment of themedical history of the study par-
ticipants nor in the management of their pain. Once she had
forwarded the results of peg and electronic algometry to the
data manager, she was granted access to the participants’ files
to extract descriptive data that she sent to the data manager.
To improve consistency, the index tests were performed by
the same person and in the same manner across all study
participants. To relax the participants, the measurements
were performed in their rooms.
The areas under the receiver operating characteristic
curves (AUC) enabled a direct comparison of both algometry
techniques (roc, Stata SE, version 12.1). The larger an AUC,
the higher the probability of detecting functional pain if
there is any and of excluding it if there is none. An AUC
of 50% would correspond to an uninformative test, and an
AUC of 100% to a perfectly discerning test. Graphs were
drawn for visual comparison (roccomp, Stata SE, version
12.1). Statistical significancewas tested by noninferiority com-
parisons. To compute the standard error of the difference bet-
ween the AUCs of the index tests, the correction factor for
the correlation between these two techniques was needed,
which was computed by the functional-pain-nonfunctional-
pain average of their correlation coefficients (ktau, Stata SE,
version 12.1) and the average of their AUCs (roctab, Stata/SE,
version 12.1) [27].
Noninferiority of peg to electronic algometry was
assumed if theAUCof peg algometry was at least 80% as large
as the AUC of electronic algometry against a 𝑝 value smaller
than 0.05 [20].
The reference variable was “functional versus nociceptive
and neuropathic pain,” and the two classification variables to
compare were “numerical pain rating of peg algometry” and
“pain threshold of electronic algometry in kilopascals.”
The aim was to detect noninferiority of peg to electronic
algometry, as defined above, with 80% power. Assuming a
rank correlation of peg and electronic algometry of 0.4 [20]
and an AUC of electronic algometry of 80% [15, 16], a min-
imum of 60 study participants with functional pain and 60
study participants with nociceptive pain were required for
this aim [27].
The study participants were described using Stata/SE,
version 12.1. The description included “peg algometry rating
from 0 to 10 in 1/2 units,” “electronic algometry in kilopas-
cals,” “age, sex, pain onset, and pain localization,” “numeric
analogue scales from 0 to 10 in 1/2 units,” and medication.
“Numeric analogue scales from 0 to 10 in 1/2 units” included
musculoskeletal pain and mood. Medication included “anal-
gesics,” “antidepressants (yes/no),” and “antiepileptic drugs
(yes/no).” Analgesics were categorized as “strong opiates,”
“weak opiates,” “nonopiate analgesics only,” and “no anal-
gesics.” A table describes these variables as counts and per-
centages if they are binary or categorical and other types of
variables as means and standard deviations. It also provides
the ranges of the index tests for the identification of outliers.
3. Results
Of 166 individuals hospitalized for musculoskeletal pain
from May to August 2009 and January to March 2010, 157
consented to participate, of which none had to be excluded
(Figure 1). The nociceptive pain group of 89 participants
included nine patients with neuropathic rather than nocicep-
tive pain (Figure 2). Due to the delayed process until referral
to specialized therapeutic centers [3], study participants with
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Department of psychosomatic medicine: 19 Department of orthopedics: 70
Degenerative: 16 Traumatic: 3 Degenerative: 36 Traumatic: 34
Neuropathic 
(lesions of the 
nervous system): 0
Nociceptive (lesions 
of innervated 
tissue): 16
Neuropathic 
(lesions of the 
nervous system): 9
Nociceptive (lesions 
of innervated 
tissue): 27
Nonfunctional chronic pain: 89
Figure 2: Classification of nonfunctional pain according to study site and pathology. Nine individuals of the nociceptive pain group of 89
participants had neuropathic rather than nociceptive pain. This number was too small for sensitivity analyses.
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Figure 3: Visual comparison of peg and electronic algometry in discerning functional fromnociceptive pain: receiver operating characteristic
curves. Axes: 𝑥-axis = 100% − specificity in %; 𝑦-axis = sensitivity in %. Peg algometry: the red circles reflect the maximum of 21 possible test
results given by the 0 to 10 pain rating at intervals of 0.5 points. Electronic algometry: the blue dashed line reflects the multitude of possible
test results provided by the pressure pain measurement unit “kilopascal” with standard deviations ranging between 72 and 97 kilopascals.
this condition had experienced pain for a longer period of
time and differed in medications (Table 1).
The visual comparison showed that, for finger and ear
measures, the AUCs for peg algometry were larger than those
for electronic algometry (Figure 3).
Thenoninferiority comparison inTable 2 showed that, for
finger measures, the AUC for peg algometry was at least 95%
as large as that for electronic algometry (𝑝 = 0.038), and for
ear measures, the AUC for peg algometry was at least equally
as large as that for electronic algometry (𝑝 = 0.003).
4. Discussion
Taken together, we found that finger peg algometry is at
least 95% as reliable as finger electronic algometry in dis-
tinguishing functional from nociceptive and neuropathic
musculoskeletal pain, and we found that ear peg algometry
is even equally good or better than ear electronic algometry.
Cost-effective and more easily manageable alternatives for
electronic algometry were developed in the past [18], but
we were the first to investigate their accuracy to differenti-
ate functional from nociceptive musculoskeletal pain. One
strength of this study is that we used identical conditions
to compare a new screening test accessible for primary care
with an established research test of known accuracy [14–17].
This means that most potential limitations would affect the
absolute performance of both tests, thereby leaving the com-
parison between them only minimally affected, it at all.
A pain history of unsuccessful examinations for and treat-
ment of assumed organic pain-sustaining factors is a strong
reference standard because it has very important clinical
implications for the patients [3, 4]. However, this reference
standardmight also include the limitation of unequal years of
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Table 1: Cross-sectional description of study participants with functional and nociceptive paina.
Functional pain Nociceptive pain
Number of participants (denominator) 68 89
Peg algometry rating from 0 to 10 in 1/2 units
Mean finger pressure pain (SD) 4.5 (3.0) 1.5 (1.5)
Mean ear lobe pressure pain (SD) 7.5 (2.5) 4.5 (2.5)
Range of finger pressure painb 0 to 10 0 to 7
Range of ear lobe pressure painb 1 to 10 0 to 10
Electronic algometry in kilopascals
Mean finger pain threshold (SD) 156 (96) 228 (97)
Mean ear lobe pain threshold (SD) 125 (85) 164 (72)
Range of finger pain thresholdb 12 to 467 71 to 676
Range of ear lobe pain thresholdb 2 to 461 47 to 368
Age, sex, pain onset, and pain localization
Mean age in years (SD) 46 (12) 57 (16)
Number of women (%) 40 (59) 37 (42)
Mean pain duration in months (SD) 98 (114) 35 (75)
Number of pain onsets before the 50th birthday (%) 59 (87) 40 (45)
Number of patients with multilocular pain (%) 56 (82) 33 (37)
Numeric analogue scales from 0 to 10 in 1/2 units
Mean intensity of musculoskeletal pain (SD) 6.5 (2.0) 4.0 (2.0)
Mean mood (SD) 6.0 (2.5) 4.0 (2.0)
Medication
Number of patients
With strong opiates (%) 10 (15) 14 (16)
With weak opiates (%)c 12 (18) 6 (7)
With nonopiate analgesics only (%) 33 (49) 67 (75)
Without analgesics (%) 13 (19) 2 (2)
Number of patients with antidepressants (%) 58 (85) 17 (19)
Number of patients with antiepileptic drugs (%) 16 (24) 10 (11)
aNo missing data; bno outliers; cweak opiates = tramadol and codeine.
Table 2: Noninferiority comparison of peg and electronic algometry in discerning functional from nociceptive pain: areas under the receiver
operating characteristic curves (AUC)a.
AUC in % of a perfectly discerning test (95% CI) Difference (95% CI) 𝑝 value
Peg algometry Electronic algometry Crude
AUC of peg minus 95% of
the AUC of electronic
algometry
Finger measures 79 (71 to 86) 72 (64 to 80) 7 (−3 to 16) 0.18 11 (1 to 20) 0.04
Ear measures 81 (74 to 88) 66 (57 to 75) 15 (5 to 24) 0.003 18 (8 to 27) < 0.001
aNo missing data.
pain history and medication between study participants with
functional and nociceptive pain, as well as corroboration of
the reference standard in a sample referred to specialized cen-
ters rather than in general practices. In addition, we cannot
exclude that the patients spoke about their pain history to the
person who performed the index tests. However, this person
ignored the study objectives and had no competing interests.
In addition, the pressure algometry depends on the percep-
tion of the patients but not on the perception of the tester.
Prior to the results of this study, there was no good reference
standard for an early pain stage [11–13], and only at an early
pain stage there are patients certainly blind to their condition
who do not differ substantially in terms of medication.
Since we found that an economical device is at least as
good at screening for functional musculoskeletal pain as a
tried and trusted device used in specialized departments,
screening is also possible in primary care.This does notmean
that peg algometry provides diagnostic certitude at the very
onset but that it is a useful screening tool. At onset, mus-
culoskeletal pain might result from altered function of the
6 Pain Research and Treatment
nervous system (functional pain) and from nociceptive or
neuropathic stimuli such as injury, inflammation, or degen-
eration. In the event of suspected functional pain, this would
make a parallel investigation of different causesmandatory [3,
7]. But as pain starts to become chronic [1], having screened
for central nervous system sensitization may support general
practitioners in determining whether an injury or a disease
might have been overseen or inadequately treated, or whether
it is more likely that the pain is functional [3, 5, 7].
It would be interesting to know how well peg algometry
carried out before initiation of extensive diagnostic and ther-
apeutic procedures predicts their success. Since we obtained
our findings in a highly specialized setting, caution is appro-
priate when generalizing them to primary care. However, a
gain in certitude regarding generalizability would require a
long observation period in a primary care setting for which
the expensive electronic algometry is not accessible. Then
again, we found that peg algometry is at least as good as
electronic algometry. We deduce that the research we suggest
is possible only with peg algometry. In an upcoming third
phase, we plan to investigate the difference in therapeutic suc-
cess between taking into account and ignoring the screening
results of peg algometry.
What we can say now is that general practitioners can
start appropriate pain treatment earlier, because early sep-
aration of functional from nociceptive and neuropathic
pain becomes easier. Interested general practitioners may
manufacture their own peg algometers, which is also possible
in countries with few resources. They may explain to their
patients that a short innocuous test performed instantly with
a small device of familiar appearance can help to tell if
there is probably no alteration of the painful tissue behind
the very frequent condition of musculoskeletal pain. If the
test unmasks an enhanced reactivity of the central nervous
system to pain stimuli (central nervous system sensitization)
[5, 7], patients may prefer knowing this early rather than
hearing that “nothing” has been found. Awareness that their
central nervous system is even likely to continue reacting after
removal of the initial pain stimulus might reduce insecurity
if the pain becomes chronic [9]. Even if patients have a
combination of functional and nociceptive pain, unmasking
a hypersensitivity component might help understanding why
the standard treatment remains unsatisfactory and additional
treatment modalities are required.
As appropriate pain treatment can start earlier, the prog-
noses of functional, nociceptive, and perhaps even neuropa-
thic pain are likely to improve [3, 4]. This might be perceived
with more personal satisfaction than years of diagnostic and
therapeutic incertitude [3, 9].
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